J.K. Cement (532644) Q3 24/25 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 24/25 earnings summary
9 Jan, 2026Executive summary
Q3 net sales ranged from INR 2,606 crores to ₹2,930.28 Cr, with sequential growth but a slight year-over-year decline; consolidated net profit for Q3 was between ₹189.87 Cr and INR 205 crores.
Q3 EBITDA was reported between INR 489 crores and ₹492 crore, up over 73% sequentially but down year-over-year.
Board approved acquisition of 60% equity in Saifco Cements (J&K) for INR 174 crores, expanding presence in Jammu & Kashmir.
Unaudited standalone and consolidated financial results for Q3 and nine months ended 31 Dec 2024 were approved and published.
Approval granted for incorporation of a wholly owned Section 8 company to promote startups and incubators.
Financial highlights
Q3 EBITDA margin improved to 18.7% standalone, with consolidated margin at 16.79%; Q3 EBITDA per ton was INR 1,040, up sequentially but down year-over-year.
Net debt ranged from INR 2,582 crores to INR 3,108 crores; net debt to EBITDA was reported at both 1.29x and 1.74x.
9-month consolidated net sales were between INR 7,493 crores and ₹8,297.97 Cr, with EBITDA down 15-16% year-over-year.
Standalone Q3 EPS was 26.51, consolidated Q3 EPS was 24.54.
Incentives contributed around INR 85-90 crores in Q3, including a one-time INR 10-15 crores for prior period items.
Outlook and guidance
FY26 volume growth guided at 10% from FY25 exit levels; premium cement share targeted to exceed 20% in two years.
Paints business expected to reach INR 450 crores revenue in FY26 and INR 600 crores in FY27, with EBITDA break-even by FY27.
6 MTPA grey cement capacity expansion progressing, with Bihar unit commissioning by December 2025.
Amalgamation of Toshali Cement Private Limited is underway, pending regulatory approval.
Q4 profitability will depend on price increases over Q3; incremental EBITDA expected from any price rise.
Latest events from J.K. Cement
- Q1 FY25 delivered strong profit and margin growth, new capacity, and progress on ESG goals.532644
Q1 24/253 Feb 2026 - Q3 FY26 saw strong growth, capacity expansion, and full compliance amid ongoing litigation.532644
Q3 25/2619 Jan 2026 - Lower margins amid cost pressures; expansion, amalgamation, and efficiency moves underway.532644
Q2 24/2518 Jan 2026 - Q4 and FY25 delivered strong growth, margin gains, and a ₹15 dividend recommendation.532644
Q4 24/256 Jan 2026 - Strong revenue, EBITDA, and profit growth, with major expansions and acquisitions underway.532644
Q1 25/266 Jan 2026 - Strong revenue and profit growth, with major expansions and improved margins achieved.532644
Q2 25/264 Nov 2025